104 related articles for article (PubMed ID: 2473000)
1. Gastrin-producing ovarian cystadenocarcinoma: sensitivity to secretin and SMS 201-995.
Heyd J; Livni N; Herbet D; Mor-Yosef S; Glaser B
Gastroenterology; 1989 Aug; 97(2):464-7. PubMed ID: 2473000
[TBL] [Abstract][Full Text] [Related]
2. Ovarian carcinoma as a cause of Zollinger-Ellison syndrome. Natural history, secretory products, and response to provocative tests.
Maton PN; Mackem SM; Norton JA; Gardner JD; O'Dorisio TM; Jensen RT
Gastroenterology; 1989 Aug; 97(2):468-71. PubMed ID: 2663614
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the in vivo and in vitro inhibition of gastrin secretion from gastrinoma by a somatostatin analogue (SMS 201-995).
Ellison EC; Gower WR; Elkhammas E; Woltering EA; Sparks J; O'Dorisio TM; Fabri PJ
Am J Med; 1986 Dec; 81(6B):56-64. PubMed ID: 2879448
[TBL] [Abstract][Full Text] [Related]
4. Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of apudomas.
Ellison EC; O'Dorisio TM; Sparks J; Mekhjian HS; Fromkes JJ; Woltering EA; Carey LC
Surgery; 1986 Aug; 100(2):437-44. PubMed ID: 2426819
[TBL] [Abstract][Full Text] [Related]
5. Zollinger-Ellison syndrome due to a gastrin-producing ovarian cystadenocarcinoma.
Bollen EC; Lamers CB; Jansen JB; Larsson LI; Joosten HJ
Br J Surg; 1981 Nov; 68(11):776-7. PubMed ID: 7296246
[No Abstract] [Full Text] [Related]
6. Somatostatin analogue (SMS 201-995) in patients with gastrinomas.
Vinik AI; Tsai S; Moattari AR; Cheung P
Surgery; 1988 Nov; 104(5):834-42. PubMed ID: 2903562
[TBL] [Abstract][Full Text] [Related]
7. Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome.
Mozell E; Woltering EA; O'Dorisio TM; Fletcher WS; Sinclair AJ; Hill D
Surg Gynecol Obstet; 1990 Jun; 170(6):476-84. PubMed ID: 2188384
[TBL] [Abstract][Full Text] [Related]
8. Serous papillary cystadenocarcinoma associated with alpha-fetoprotein production.
Higuchi Y; Kouno T; Teshima H; Akizuki S; Kikuta M; Ohyumi M; Yamamoto S
Arch Pathol Lab Med; 1984 Sep; 108(9):710-2. PubMed ID: 6205636
[TBL] [Abstract][Full Text] [Related]
9. Conservative management of the Zollinger-Ellison syndrome. Ectopic gastrin production by an ovarian cystadenoma.
Long TT; Barton TK; Draffin R; Reeves WJ; McCarty KS
JAMA; 1980 May; 243(18):1837-9. PubMed ID: 7365959
[TBL] [Abstract][Full Text] [Related]
10. Mechanism for increase of gastrin release by secretin in Zollinger-Ellison syndrome.
Chiba T; Yamatani T; Yamaguchi A; Morishita T; Nakamura A; Kadowaki S; Fujita T
Gastroenterology; 1989 Jun; 96(6):1439-44. PubMed ID: 2565843
[TBL] [Abstract][Full Text] [Related]
11. The use of somatostatin analog in gastroenteropancreatic tumors other than carcinoid.
Vinik AI; Lloyd R; Cho K
Metabolism; 1990 Sep; 39(9 Suppl 2):156-62. PubMed ID: 2402220
[TBL] [Abstract][Full Text] [Related]
12. Serum gastrin and its response to secretin in hyperparathyroid patients.
Selking O; Johansson H; Lundqvist G
Acta Chir Scand; 1981; 147(8):649-55. PubMed ID: 7344385
[TBL] [Abstract][Full Text] [Related]
13. Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans.
Creutzfeldt W; Lembcke B; Fölsch UR; Schleser S; Koop I
Am J Med; 1987 May; 82(5B):49-54. PubMed ID: 2884879
[TBL] [Abstract][Full Text] [Related]
14. Gastrin-producing ovarian mucinous cystadenoma.
Julkunen R; Partanen S; Salaspuro M
J Clin Gastroenterol; 1983 Feb; 5(1):67-70. PubMed ID: 6841951
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of gastrin release by secretin is mediated by somatostatin in cultured rat antral mucosa.
Wolfe MM; Reel GM; McGuigan JE
J Clin Invest; 1983 Nov; 72(5):1586-93. PubMed ID: 6138366
[TBL] [Abstract][Full Text] [Related]
16. Serum gastrin and secretin levels after the Exalto-Mann-Williamson procedure.
Tasse DP; Kolts BE; McGuigan JE; Woodward ER; Dragstedt LR
Arch Surg; 1975 Dec; 110(12):1482-4. PubMed ID: 1200832
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of omeprazole induced hypergastrinaemia by SMS 201-995, a long acting somatostatin analogue in man.
Meijer JL; Jansen JB; Crobach LF; Biemond I; Lamers CB
Gut; 1993 Sep; 34(9):1186-90. PubMed ID: 8406151
[TBL] [Abstract][Full Text] [Related]
18. Effect of secretin on release of heterogeneous forms of gastrin.
Straus E; Greenstein AJ; Yalow RS
Gut; 1975 Dec; 16(12):999-1005. PubMed ID: 1218824
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a human gastrinoma in nude mice.
Upp JR; Trudel JL; Townsend CM; Alexander RW; Rajaraman S; Nealon WH; Greeley GH; Thompson JC
Surgery; 1988 Dec; 104(6):1037-45. PubMed ID: 3194831
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory actions of a somatostatin analog SMS 201-995 on endocrine secretion from the isolated perfused stomach and pancreas of the rat.
Verchere CB; Kwok YN; Brown JC
Pharmacology; 1993; 46(1):50-60. PubMed ID: 8094569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
